A Study to Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Advanced Cancer (Solid Tumours) Positive for B7-H6

Clinical trial NCT06091930 · TERMINATED

Trial details

NCT number: NCT06091930
Sponsor: Boehringer Ingelheim
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Gastrointestinal Cancer Lung Cancer Pancreatic Cancer Colorectal Cancer Head and Neck Cancer Liver Cancer

Start date: 2024-02-16
Primary completion: 2025-08-15
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.